Mounting concerns over government's drug-related policies

Published: 2002-10-05 07:00:00

Updated: 2002-10-05 07:00:00

Pharmaceutical business sources say that a series of drug-related policies designed to discourage the use of high-priced drugs, such as minimum actually transacted pricing system, drug pricing re-evaluation system and feasibility assessment system for proper use of insurance drugs, are merely int...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK